About Our Medical Review Process

SDC is committed to the highest safety practices with all of our products. Each product is thoroughly tested in a safe and registered lab environment to ensure the highest level of quality and safety that’s delivered to our customers. Please contact support if you have any questions. Our team is committed to providing transparent info on psychedelics that is supported by evidence.

Dr. Jake M. Donaldson, MD, PhD, FRCPC, FACP (Chief Medical Officer, SDC, 2018-present)

Biography:

Dr. Donaldson received his MD-PhD in 1992 from McMaster University in Hamilton, Ontario, where he studied at the Michael G. DeGroote School of Medicine. Prior to spending three years as a psychiatry resident at Columbia University and the New York State Psychiatric Institute, he completed a year of internal medicine training at the Juravinski Hospital.

Later, Dr. Donaldson relocated to Austin, Texas, for the remainder of his residency. Additionally, he was a research fellow at the Dell Medical School’s Center for Psychedelic Research & Therapy, where his work advanced the use of psychedelics in the treatment of mental health conditions.

Currently, Dr. Donaldson serves on the board of the American Academy of Research on Psychedelics (AAP) and the Center for Neuroscience of Psychedelics (CNP), as a forerunner in the development of psychedelic healthcare and a leader in disseminating best practices to professionals in the fields of medicine and mental health.

Education & Training:

Michael G. DeGroote School of Medicine, MD/PhD – 1992

McMaster University, PhD (Neuroscience) – 1991

Internship – Internal Medicine, Juravinski Hospital

Residency – Texas Health Arlington Memorial Hospital

Research Fellowship – Dell Medical School’ Center for Psychedelic Research & Therapy

Postdoctoral – Center for Neuroscience of Psychedelics

About our Medical Review Process:

SDC is dedicated to employing only the highest safety protocols with all of our products. To guarantee that our customers receive the highest level of quality and safety, each product is thoroughly tested in a secure, accredited laboratory setting.

For assistance, simply get in touch with support. Our staff is dedicated to giving accurate, evidence-based information about psychedelics.

Recommendation

“Here at SDCTM the development of our products, here at SDCTM are based on utilization of comprehensive, substantiated, and scientifically sound clinical evidence.

 We hope to advance the use of psychedelics for the treatment of mental health issues. By utilizing and spreading accurate, reliable, and scientifically sound content, our objective is to disseminate knowledge concerning psychedelic medicine and its potential to revolutionize mental healthcare” – Dr. Donaldson

ADDRESS: British Columbia, Canada
EMAIL: [email protected]
WORKING DAYS/HOURS: 7 Days a Week / 8:00 AM – 4:00 PM PST

All rights reserved 2020

0